Yesterday, Oct. 23, 2015, 31 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $53.62 to $25,164,816.00.

Highlighted Stocks Traded by Insiders:

Cell Therapeutics (CTIC) - FREE Research Report

Singer Jack W, who is EVP, Global Medical Affairs at Cell Therapeutics, sold 15,000 shares at $1.62 on Oct. 23, 2015. Following this transaction, the EVP, Global Medical Affairs owned 1.3 million shares meaning that the stake was reduced by 1.11% with the 15,000-share transaction.

The shares most recently traded at $3.01, up $1.39, or 46.1% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares sold: 1.1 million
  • 12-Week # shares sold: 1.3 million
  • 24-Week # shares sold: 1.3 million

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

PrivateBancorp (PVTB) - FREE Research Report

Wiatr Leonard, who is Chief Risk Officer at PrivateBancorp, sold 350 shares at $40.58 on Oct. 23, 2015. Following this transaction, the Chief Risk Officer owned 48,981 shares meaning that the stake was reduced by 0.71% with the 350-share transaction.

The shares most recently traded at $41.23, up $0.65, or 1.58% since the insider transaction. Historical insider transactions for PrivateBancorp go as follows:

  • 4-Week # shares sold: 16,253
  • 12-Week # shares sold: 16,253
  • 24-Week # shares sold: 17,553

The average volume for PrivateBancorp has been 516,800 shares per day over the past 30 days. PrivateBancorp has a market cap of $3.2 billion and is part of the financial sector and banking industry. Shares are up 25.45% year-to-date as of the close of trading on Friday.

PrivateBancorp, Inc. operates as the holding company for The PrivateBank and Trust Company that provides customized financial services to middle market companies, business owners, executives, entrepreneurs, and families in the United States. The stock currently has a dividend yield of 0.1%. The company has a P/E ratio of 18.9. Currently, there are 3 analysts who rate PrivateBancorp a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PVTB - FREE

TheStreet Quant Ratings

rates PrivateBancorp as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, growth in earnings per share, increase in net income and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

PrivateBancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

KLA-Tencor (KLAC) - FREE Research Report

Higgins Bren D., who is EVP & Chief Financial Officer at KLA-Tencor, sold 567 shares at $64.39 on Oct. 23, 2015. Following this transaction, the EVP & Chief Financial Officer owned 2,747 shares meaning that the stake was reduced by 17.11% with the 567-share transaction.

Kirk Michael, who is Executive Vice President at KLA-Tencor, sold 16,204 shares at $64.39 on Oct. 23, 2015. Following this transaction, the Executive Vice President owned 834 shares meaning that the stake was reduced by 95.11% with the 16,204-share transaction.

The shares most recently traded at $65.23, up $0.84, or 1.29% since the insider transaction. Historical insider transactions for KLA-Tencor go as follows:

  • 4-Week # shares sold: 3,108
  • 12-Week # shares bought: 67
  • 12-Week # shares sold: 35,884
  • 24-Week # shares bought: 67
  • 24-Week # shares sold: 50,663

The average volume for KLA-Tencor has been 2.2 million shares per day over the past 30 days. KLA-Tencor has a market cap of $10.2 billion and is part of the technology sector and electronics industry. Shares are down 7.07% year-to-date as of the close of trading on Friday.

KLA-Tencor Corporation designs, manufactures, and markets process control and yield management solutions worldwide. The stock currently has a dividend yield of 3.2%. The company has a P/E ratio of 26.3. Currently, there are 4 analysts who rate KLA-Tencor a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KLAC - FREE

TheStreet Quant Ratings

rates KLA-Tencor as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk. Get the full

KLA-Tencor Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.